Article

Consumer Lawsuits Filed Against Anthem for Denying Harvoni Coverage

Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni.

Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni. Both lawsuits claim the insurer denied coverage for Harvoni, because the amount of liver damage sustained by the women was insufficient to warrant payment for the drug, and the treatment was not medically necessary.

The arguments go back and forth. In its denial letter sent to 1 of the plaintiffs, Anthem said that the women's liver had not yet sustained enough damage. The plaintiff argues that preventing her liver from getting to that stage would be the point of her treatment.

Read the complete report on The Wall Street Journal: http://on.wsj.com/1FUq4Eu

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
EHA 2025 Congress Recap | Image Credit: Venngage
Ashley Yocum, PhD
Dr Matthew Matasar
Dr Xavier Leleu
Dr Marina Kremskayana
Dr Sundar Jagannath
5 experts are featured in this series
4 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo